EUVIMEDEUVIMED entdecken
Open Access

Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System

Susanna D Mitro, Wendy Dyer, Catherine Lee, Ameek Bindra, Lana Wang, Miranda Ritterman Weintraub, Monique M Hedderson, Eve Zaritsky

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.5235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Susanna D Mitro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Research, Kaiser Permanente Northern California, Pleasanton. Hauptthemen laut MEDLINE: Ethnicity, Leiomyoma, Racial Groups, Uterine Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Uterine fibroids are benign tumors that can cause severe symptoms. Fibroid burden among Asian or Pacific Islander individuals, particularly in specific subgroups, remains largely unexamined.

Objective

To describe fibroid diagnosis rates by race and ethnicity. Design, Setting, and Participants This retrospective cohort study (January 2009 to December 2022) used data from electronic health records of the Kaiser Permanente Northern California (KPNC) integrated health care system. Eligible participants included female (sex assigned at birth) KPNC members aged 18 to 54 years with at least 12 months of continuous membership, no prior fibroid diagnosis, and no history of hysterectomy. Data were analyzed January to September 2024. Exposure Race and ethnicity was categorized into 9 groups: Black (African American, other Black [ie, any Black race or ethnicity not otherwise specified], and unknown Black race or ethnicity), East Asian (Chinese, Japanese, and Korean), Hispanic (Hispanic or Latino), South Asian (Asian Indian, Bangladeshi, East Indian, Nepali, Sri Lankan, and any South Asian ethnicity not otherwise specified), Southeast Asian (Filipino, Vietnamese, and other Southeast Asian [ie, any Southeast Asian ethnicity not otherwise specified]), White (White or White Middle Eastern), other Asian or Pacific Islander (Native Hawaiian or Pacific Islander, multiethnic Asian, and other or unspecified Asian ethnicity [ie, any Asian ethnicity not otherwise specified]), other races and ethnicities (American Indian or Alaska Native and multiracial), and unknown race or ethnicity. Main Outcomes and Measures Incident fibroid diagnosis was identified using diagnostic codes. Poisson regression models were used to calculate incidence rates of fibroid diagnosis by racial and ethnic group, standardized to the 2022 US female population. Incidence rate ratios (IRRs) and 95% CIs compared incidence within each racial and ethnic group with White participants.

Results

A total of 1 917 794 patients were included (median [IQR] percentage, 7% [6%-7%] Black; 5% [5%-6%] East Asian; 22% [21%-23%] Hispanic; 3% [2%-3%] South Asian; 7% [7%-8%] Southeast Asian; 42% [39%-45%] White; 8% [6%-10%] other Asian or Pacific Islander; 2% [2%-2%] of other races and ethnicities; 4% [4%-5%] unknown or missing race and ethnicity), and 84 206 patients (4.4%) received a first fibroid diagnosis during the study period. Compared with White patients, there was a higher rate of fibroid diagnosis among Southeast Asian (IRR, 1.29; 95% CI, 1.26-1.33), East Asian (IRR, 1.47; 95% CI, 1.43-1.51), and South Asian patients (IRR, 1.71; 95% CI, 1.65-1.78). Black (IRR, 3.11; 95% CI, 3.05-3.17) and Hispanic patients (IRR, 1.37; 95% CI, 1.34-1.39) also had elevated rates of fibroid diagnosis. All Asian patients were less likely than other groups to have ICD-9 or ICD-10 coded symptoms before diagnosis. Conclusions and Relevance In this cohort study of nearly 2 million KPNC patients, South Asian, East Asian, Southeast Asian, Hispanic, and Black patients had higher fibroid diagnosis rates than White patients. If diagnosis rates reflect true variation in disease prevalence, future research should identify sources of these disparities and strategies to reduce them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EthnicityLeiomyomaRacial GroupsUterine NeoplasmsAdolescentAdultFemaleHumansMiddle AgedYoung AdultCaliforniaDelivery of Health Care, IntegratedRetrospective StudiesAsianAsian American Native Hawaiian and Pacific Islander

Autor:innen und Institutionen

  • Division of Research, Kaiser Permanente Northern California, Pleasanton.
  • Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, Oakland.
  • Department of Graduate Medical Education, Oakland Medical Center, Kaiser Permanente Northern California, Oakland.

Förderung

  • NIAMS NIH HHS

Zitieren

APA

Mitro, S. D., Dyer, W., Lee, C., Bindra, A., Wang, L., Ritterman Weintraub, M., Hedderson, M. M., & Zaritsky, E. (2025). Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.5235

Vancouver

Mitro SD, Dyer W, Lee C, Bindra A, Wang L, Ritterman Weintraub M, et al. Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.5235

BibTeX
@article{Mitro2025,
  author = {Mitro, Susanna D and Dyer, Wendy and Lee, Catherine and Bindra, Ameek and Wang, Lana and Ritterman Weintraub, Miranda and Hedderson, Monique M and Zaritsky, Eve},
  title = {Uterine Fibroid Diagnosis by Race and Ethnicity in an Integrated Health Care System},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.5235}
}
Kostenlos starten →